Saykı Arslan, M. Et Al. 2014. The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor κB Ligand and Osteoporosis in Patients with Prolactinoma. Endocrine Society's 96th Annual Meeting and Expo .

Saykı Arslan, M., ŞAHİN, M., Tutal, E., Melia, K., TOPALOĞLU, O., UÇAN, B., ... Demirci, T.(2014). The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor κB Ligand and Osteoporosis in Patients with Prolactinoma . Endocrine Society's 96th Annual Meeting and Expo

Saykı Arslan, Müyesser Et Al. "The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor κB Ligand and Osteoporosis in Patients with Prolactinoma," Endocrine Society's 96th Annual Meeting and Expo, 2014

Saykı Arslan, Müyesser S. Et Al. "The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor κB Ligand and Osteoporosis in Patients with Prolactinoma." Endocrine Society's 96th Annual Meeting and Expo , 2014

Saykı Arslan, M. Et Al. (2014) . "The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor κB Ligand and Osteoporosis in Patients with Prolactinoma." Endocrine Society's 96th Annual Meeting and Expo .

@conferencepaper{conferencepaper, author={Müyesser Saykı Arslan Et Al. }, title={The Relationship Between Fibroblast Growth Factor 23, Osteoprotegerin, Receptor Activator of Nuclear Factor κB Ligand and Osteoporosis in Patients with Prolactinoma}, congress name={Endocrine Society's 96th Annual Meeting and Expo}, city={}, country={}, year={2014}}